Naari Pharma Private Limited, a Bengaluru-based vertically integrated women’s health pharma business focused on hormones, announced that it has entered into a definitive asset purchase agreement to acquire 10 Abbreviated New Drug Applications (ANDAs) for the U.S. market from Intas Pharmaceuticals Ltd. The portfolio acquired comprises eight U.S. FDA approved ANDAs and two products pending…
Naari Pharma Private Limited announced that it has received an equity investment of about Rs. 125 crore from Ascent Capital, an India-focused growth capital provider that has backed more than 60 entrepreneurs build businesses across diverse sectors such as pharmaceuticals, healthcare, technology, financial services and consumer brands. Commenting on the development, Prithi S Kochhar, Co-Founder…